TrianglePUBLICATIONS · 31386611
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2019 Dec 1
- First author
- Twist CJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Twist CJ
- type
- Author
- name
- Schmidt ML
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- London WB
- type
- Author
- name
- Tenney SC
- type
- Author
- name
- Marachelian A
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Collins MH
- type
- Author
- name
- Esiashvili N
- type
- Author
- name
- Adkins ES
- type
- Author
- name
- Mattei P
- type
- Author
- name
- Handler M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Twist CJ
- type
- Author
- name
- Schmidt ML
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- London WB
- type
- Author
- name
- Tenney SC
- type
- Author
- name
- Marachelian A
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Collins MH
- type
- Author
- name
- Esiashvili N
- type
- Author
- name
- Adkins ES
- type
- Author
- name
- Mattei P
- type
- Author
- name
- Handler M
- type
- Author
- bibliography ids
- nci-bib-8d8339604b962d8f29cd2443
- book metadata
- content sha256
- 274803125c0f24a94f53b2945ffa3f3bd60704309006835858c439f7131a451b
- document type
- citation
- dois
- 10.1200/JCO.19.00919
- electronic publication date
- display
- 2019 Aug 6
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31386611
- immutable id
- pubmed:31386611@274803125c0f24a94f53b2945ffa3f3bd60704309006835858c439f7131a451b
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 34
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3243-3255
- volume
- 37
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 31386611
- provenance
- batch id
- 23ffe1e2a9e160b6dca0
- provider
- NCBI PubMed ESummary
- record sha256
- 4dd252beedfe0b286041259f2e17277234f22376585b33443507336005e34699
- response sha256
- d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
- retrieved at
- 2026-09-09T23:47:44.690737+00:00
- publication date
- display
- 2019 Dec 1
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
Preserved source evidence · Independent clinical review pending · Not medical advice